Since previous reports suggest that upregulation of atrogin-1 and MuRF-1 are responsible for the muscle degeneration in cancer patients9, we tested the expression levels of atrogin-1, MuRF-1 and FoxO3a by qPCR analysis and western blotting. Here, FBXO32 is linked to cancer.